首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and biological evaluation of novel non-racemic indole-containing allocolchicinoids
【24h】

Synthesis and biological evaluation of novel non-racemic indole-containing allocolchicinoids

机译:新型非外消旋吲哚的含累菌蛋白的合成与生物学评价

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Two novel indole-containing allocolchicinoids were prepared from naturally occurring colchicine exploiting the Curtius rearrangement and tandem Sonogashira coupling/Pd-catalyzed cyclization as the key transformations. Their cytotoxic properties, apoptosis-inducing activity, tubulin assembly inhibition and short-time cytotoxic effects were investigated. Compound 7 demonstrated the most pronounced anti-cancer activity: IC 50 ? Graphical abstract Display Omitted Highlights ? Two pyrrole-based allocolchicinoids were prepared from commercial colchicine. ? Compounds exhibit excellent cytotoxicity towards epithelial cell lines. ? 7 and 12 induced cell accumulation in the G2/M phase in 2D cultures. ? 7 has lower destructive short-time effects on HT-29?cell line in comparison with colchicine.
机译:摘要制备了两种新的吲哚的甲状腺二氯纤维素由天然存在的血清曲霉,利用Curtius重排和串联Sonogashira偶联/ PD催化环化作为关键变换。 研究了它们的细胞毒性特性,凋亡诱导活性,管蛋白组装抑制和短时细胞毒性效应。 化合物7展示了最明显的抗癌活动:IC 50? 图形抽象显示省略了亮点? 由商业血清晶氨酸制备两种基于吡咯基的血焦霉素。 还是 化合物对上皮细胞系具有优异的细胞毒性。 还是 在2D培养物中诱导G2 / M相中的诱导细胞积累。 还是 7对HT-29具有较低的破坏性短时效应?与秋水仙碱相比的细胞系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号